Bone Metabolism in a Large Cohort of Patients with Systemic Sclerosis

[1]  Tzeng-Ji Chen,et al.  Increased risk of osteoporotic fractures in patients with systemic sclerosis: a nationwide population-based study , 2014, Annals of the rheumatic diseases.

[2]  Jing Wang,et al.  The association between systemic sclerosis and bone mineral density‐ a meta‐analysis of observational studies , 2014, International journal of rheumatic diseases.

[3]  M. Omair,et al.  Low Bone Density in Systemic Sclerosis. A Systematic Review , 2013, The Journal of Rheumatology.

[4]  E. Wouters,et al.  Osteoporosis in chronic obstructive pulmonary disease , 2013, Expert review of respiratory medicine.

[5]  D. Sangari,et al.  Bone Mineral Density, Bone Turnover Markers and Fractures in Patients with Systemic Sclerosis: A Case Control Study , 2013, PloS one.

[6]  S. Adami,et al.  Involvement of WNT/β-catenin Signaling in the Treatment of Osteoporosis , 2013, Calcified Tissue International.

[7]  Y. Allanore,et al.  Increased risk of osteoporosis and fracture in women with systemic sclerosis: A comparative study with rheumatoid arthritis , 2012, Arthritis care & research.

[8]  R. Eastell,et al.  Bone turnover markers: use in osteoporosis , 2012, Nature Reviews Rheumatology.

[9]  Matthew R Allen,et al.  Sost downregulation and local Wnt signaling are required for the osteogenic response to mechanical loading. , 2012, Bone.

[10]  Y. Shoenfeld,et al.  Serum 25-OH vitamin D concentrations are linked with various clinical aspects in patients with systemic sclerosis: a retrospective cohort study and review of the literature. , 2011, Autoimmunity reviews.

[11]  T. Rachner,et al.  Osteoporosis: now and the future , 2011, The Lancet.

[12]  C. Cooper,et al.  Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards , 2011, Osteoporosis International.

[13]  Alessandra Dalla Gassa,et al.  Very low levels of vitamin D in systemic sclerosis patients , 2010, Clinical Rheumatology.

[14]  Y. Allanore,et al.  Vitamin D Deficiency and Insufficiency in 2 Independent Cohorts of Patients with Systemic Sclerosis , 2009, The Journal of Rheumatology.

[15]  L. Saba,et al.  Circulating Osteoprotegerin and Soluble RANK Ligand in Systemic Sclerosis , 2008, The Journal of Rheumatology.

[16]  B. Rochwerg,et al.  Patients with scleroderma may have increased risk of osteoporosis. A comparison to rheumatoid arthritis and noninflammatory musculoskeletal conditions. , 2008, The Journal of rheumatology.

[17]  R. Civitelli,et al.  Epidemiology of glucocorticoid-induced osteoporosis. , 2008, Journal of endocrinological investigation.

[18]  E. Ferrannini,et al.  Clinical and subclinical autoimmune thyroid disorders in systemic sclerosis. , 2007, European journal of endocrinology.

[19]  R. Pereira,et al.  Systemic sclerosis and bone loss: the role of the disease and body composition , 2006, Scandinavian journal of rheumatology.

[20]  E. Bonucci,et al.  Bone loss after glucocorticoid therapy , 1984, Calcified Tissue International.

[21]  A. Samara,et al.  Prognostic factors of low bone mineral density in systemic sclerosis. , 2005, Clinical and experimental rheumatology.

[22]  J. Pope,et al.  Osteoporosis in scleroderma. , 2005, Seminars in arthritis and rheumatism.

[23]  M. Ferdeghini,et al.  Reduced bone mass and normal calcium metabolism in systemic sclerosis with and without calcinosis , 1995, Clinical Rheumatology.

[24]  J. Kanis,et al.  Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: Synopsis of a WHO report , 1994, Osteoporosis International.

[25]  G. Valentini,et al.  Osteopenia in systemic sclerosis. Evidence of a participating role of earlier menopause , 1991, Clinical Rheumatology.

[26]  Ph.D. E. J. Kucharz M.D..  Thyroid disorders in patients with progressive systemic sclerosis: A review , 2005, Clinical Rheumatology.

[27]  G. Filippou,et al.  Clinical determinants of bone mass and bone ultrasonometry in patients with systemic sclerosis. , 2004, Clinical and experimental rheumatology.

[28]  G. Filippou,et al.  Bone mineral density in patients with systemic sclerosis , 2004, Annals of the rheumatic diseases.

[29]  J. Seibold,et al.  Assessment of skin, joint, tendon and muscle involvement. , 2003, Clinical and experimental rheumatology.

[30]  R. Speich,et al.  Osteoporosis Before Lung Transplantation: Association with Low Body Mass Index, but Not with Underlying Disease , 2002, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[31]  D. Wallace,et al.  Osteoporosis--less than expected in patients with scleroderma? , 2000, The Journal of rheumatology.

[32]  A Sulli,et al.  Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. , 2000, The Journal of rheumatology.

[33]  L. Carbone,et al.  Bone mineral density in scleroderma. , 1999, Rheumatology.

[34]  H. Silva,et al.  Estudo da densidade óssea na esclerodermia sistêmica , 1997 .

[35]  E. Sato,et al.  [Study of bone density in systemic scleroderma]. , 1997, Revista da Associacao Medica Brasileira.

[36]  A. Silman,et al.  The prevalence of vertebral deformity in European men and women: The european vertebral osteoporosis study , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[37]  A. Baruffo,et al.  Evidence for bone resorption in systemic sclerosis. , 1995, The Journal of rheumatology.

[38]  Kucharz Ej.  Thyroid disorders in patients with progressive systemic sclerosis: A review , 1993 .

[39]  T. Clemens,et al.  Skeletal disease in primary hyperparathyroidism , 1989, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[40]  T. Medsger,et al.  Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. , 1988, The Journal of rheumatology.

[41]  A. Masi.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). , 1980, Bulletin on the rheumatic diseases.

[42]  James F. Fries,et al.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. , 1980, Arthritis and rheumatism.